These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 39313164)
21. Interaction of a tyrosine kinase inhibitor, vandetanib with human serum albumin as studied by fluorescence quenching and molecular docking. Kabir MZ; Feroz SR; Mukarram AK; Alias Z; Mohamad SB; Tayyab S J Biomol Struct Dyn; 2016 Aug; 34(8):1693-704. PubMed ID: 26331959 [TBL] [Abstract][Full Text] [Related]
22. Discovery of a novel covalent CDK4/6 inhibitor based on palbociclib scaffold. Shan H; Ma X; Yan G; Luo M; Zhong X; Lan S; Yang J; Liu Y; Pu C; Tong Y; Li R Eur J Med Chem; 2021 Jul; 219():113432. PubMed ID: 33857728 [TBL] [Abstract][Full Text] [Related]
23. Characterization of binding mode of imatinib to human α1-acid glycoprotein. Fitos I; Simon Á; Zsila F; Mády G; Bencsura Á; Varga Z; Orfi L; Kéri G; Visy J Int J Biol Macromol; 2012 Apr; 50(3):788-95. PubMed ID: 22142793 [TBL] [Abstract][Full Text] [Related]
24. Drug-binding energetics of human α-1-acid glycoprotein assessed by isothermal titration calorimetry and molecular docking simulations. Huang JX; Cooper MA; Baker MA; Azad MA; Nation RL; Li J; Velkov T J Mol Recognit; 2012 Dec; 25(12):642-56. PubMed ID: 23192962 [TBL] [Abstract][Full Text] [Related]
25. Comprehensive views toward the biomolecular recognition of an anticancer drug, leflunomide with human serum albumin. Kabir MZ; Tayyab H; Erkmen C; Mohamad SB; Uslu B J Biomol Struct Dyn; 2024 Sep; 42(14):7257-7271. PubMed ID: 37529911 [TBL] [Abstract][Full Text] [Related]
26. Exploring the binding characteristics of bovine serum albumin with CDK4/6 inhibitors Ribociclib: Multi-spectral analysis and molecular simulation studies. Jiang SL; Chen WC; Wu YT; Sui HY; Chen D; Li L; Wu T; Shi JH J Photochem Photobiol B; 2024 Sep; 258():112992. PubMed ID: 39084139 [TBL] [Abstract][Full Text] [Related]
27. A Search for Cyclin-Dependent Kinase 4/6 Inhibitors by Pharmacophore-Based Virtual Screening, Molecular Docking, and Molecular Dynamic Simulations. Susanti NMP; Damayanti S; Kartasasmita RE; Tjahjono DH Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948218 [TBL] [Abstract][Full Text] [Related]
28. Preparation and evaluation of Gan Q; Song X; Zhang X; Zhang J Eur J Med Chem; 2020 Feb; 188():112032. PubMed ID: 31926467 [TBL] [Abstract][Full Text] [Related]
29. Intercalation of anticancer drug Palbociclib with calf-thymus DNA: new insights from molecular spectroscopic, molecular dynamic simulations and cleavage studies. Durga Priyadharshini R; Jeyashree R; Preethi R; Vennila KN; Elango KP J Biomol Struct Dyn; 2024; 42(4):1932-1939. PubMed ID: 37184154 [TBL] [Abstract][Full Text] [Related]
30. In Silico Screening of Novel α1-GABA Zheng X; Wang C; Zhai N; Luo X; Liu G; Ju X Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502550 [TBL] [Abstract][Full Text] [Related]
31. Binding characteristics and conformational changes in alpha-2-macroglobulin by the dietary flavanone naringenin: biophysical and computational approach. Ansari S; Zia MK; Ahsan H; Hashmi MA; Khan FH J Biomol Struct Dyn; 2024 Sep; 42(14):7485-7500. PubMed ID: 37498152 [TBL] [Abstract][Full Text] [Related]
32. Multi-spectral and docking assessments to explore the combination of an antiviral drug, entecavir with bovine serum albumin. Murathan Z; Zahirul Kabir M; Seng J; Mohamad SB; Uslu B Spectrochim Acta A Mol Biomol Spectrosc; 2024 Dec; 322():124792. PubMed ID: 38981287 [TBL] [Abstract][Full Text] [Related]
33. Tertiary structure of human alpha1-acid glycoprotein (orosomucoid). Straightforward fluorescence experiments revealing the presence of a binding pocket. Albani JR Carbohydr Res; 2004 Feb; 339(3):607-12. PubMed ID: 15013397 [TBL] [Abstract][Full Text] [Related]
34. Effect of hydrophobic and hydrogen bonding interactions on the potency of ß-alanine analogs of G-protein coupled glucagon receptor inhibitors. Venugopal PP; Das BK; Soorya E; Chakraborty D Proteins; 2020 Feb; 88(2):327-344. PubMed ID: 31443129 [TBL] [Abstract][Full Text] [Related]
35. Selective degradation of CDK6 by a palbociclib based PROTAC. Rana S; Bendjennat M; Kour S; King HM; Kizhake S; Zahid M; Natarajan A Bioorg Med Chem Lett; 2019 Jun; 29(11):1375-1379. PubMed ID: 30935795 [TBL] [Abstract][Full Text] [Related]
36. Selective ATP competitive leads of CDK4: Discovery by 3D-QSAR pharmacophore mapping and molecular docking approach. Rondla R; PadmaRao LS; Ramatenki V; Haredi-Abdel-Monsef A; Potlapally SR; Vuruputuri U Comput Biol Chem; 2017 Dec; 71():224-229. PubMed ID: 29153893 [TBL] [Abstract][Full Text] [Related]
37. Investigation of binding mechanism of novel 8-substituted coumarin derivatives with human serum albumin and α-1-glycoprotein. Yeggoni DP; Manidhar DM; Suresh Reddy C; Subramanyam R J Biomol Struct Dyn; 2016 Sep; 34(9):2023-36. PubMed ID: 26440860 [TBL] [Abstract][Full Text] [Related]
38. Synthesis and Biological Evaluation of Novel Song X; Gan Q; Zhang X; Zhang J Mol Pharm; 2019 Oct; 16(10):4213-4222. PubMed ID: 31424939 [TBL] [Abstract][Full Text] [Related]
39. Insight into the binding mechanisms of fluorinated 2-aminothiazole sulfonamide and human serum albumin: Spectroscopic and in silico approaches. Ayimbila F; Tantimongcolwat T; Ruankham W; Pingaew R; Prachayasittikul V; Worachartcheewan A; Prachayasittikul V; Prachayasittikul S; Phopin K Int J Biol Macromol; 2024 Oct; 277(Pt 4):134048. PubMed ID: 39116983 [TBL] [Abstract][Full Text] [Related]
40. Probing the binding mechanism of capecitabine to human serum albumin using spectrometric methods, molecular modeling, and chemometrics approach. Mousavi SF; Fatemi MH Bioorg Chem; 2019 Sep; 90():103037. PubMed ID: 31212179 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]